IDR 330.0
(-9.84%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 20.26 Billion | 7.13 Billion | 16.99 Billion | -6.39 Billion | -37.03 Billion | 8.89 Billion |
Net Income | 4.3 Billion | 7.02 Billion | 5.36 Billion | 1.25 Billion | 3.97 Billion | -6.95 Billion |
Depreciation & Amortization | 107.68 Million | 113.54 Million | 116.68 Million | 119.26 Million | 106.39 Million | 99.51 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 15.85 Billion | -7.13 Billion | 11.51 Billion | -7.76 Billion | -40.9 Billion | 15.95 Billion |
Investing Cash Flow | -7.13 Billion | -20.88 Billion | -3.36 Billion | -40.82 Billion | -24.14 Billion | -114.38 Million |
Investments in PPE | -7.13 Billion | -19.38 Billion | -1.03 Billion | -64.34 Million | -7.7 Million | -114.38 Million |
Acquisitions | - | - | 100 Million | - | -980 Million | - |
Investment purchases | - | - | - | - | -23.16 Billion | - |
Sales/Maturities of investments | - | - | - | - | 32.62 Billion | - |
Other Investing Activities | -7.13 Billion | -1.5 Billion | -2.43 Billion | -40.76 Billion | -31.63 Billion | - |
Financing Cash Flow | -15.88 Billion | -1.64 Billion | -10.6 Billion | 53.47 Billion | 61.71 Billion | -5.28 Billion |
Debt repayment | -15.88 Billion | -20.2 Billion | -15.09 Billion | -4.05 Billion | -19.67 Billion | -28.28 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 56.33 Billion | 62 Billion | 900 Million |
Other Financing Activities | -968.21 Million | 18.55 Billion | 4.48 Billion | 1.18 Billion | -19.95 Billion | -34.47 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 6.15 Billion | 14.12 Billion | 11.1 Billion | 4.86 Billion | 4.32 Billion | 830.53 Million |
Cash at end of period | 3.4 Billion | 6.15 Billion | 14.12 Billion | 11.1 Billion | 4.86 Billion | 4.32 Billion |
Capital Expenditure | -7.13 Billion | -19.38 Billion | -1.03 Billion | -64.34 Million | -7.7 Million | -114.38 Million |
Effect of forex changes on cash | - | 7.41 Billion | - | - | - | - |
Net cash flow / Change in cash | -2.74 Billion | -7.97 Billion | 3.02 Billion | 6.24 Billion | 535.7 Million | 3.49 Billion |
Free Cash Flow | 13.13 Billion | -12.24 Billion | 15.96 Billion | -6.46 Billion | -37.03 Billion | 8.78 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.52 Billion | 2.57 Billion | 222.98 Million | -2.08 Billion | 4.3 Billion | 3.76 Billion |
Depreciation & Amortization | 23.56 Million | 23.84 Million | 24.4 Million | 26.84 Million | 107.68 Million | 26.84 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 1.67 Billion | -300.07 Million | -1.08 Billion | 13.18 Billion | 15.85 Billion | 1.81 Billion |
Investing Cash Flow | - | - | - | -5.36 Billion | -7.13 Billion | -1 Billion |
Investments in PPE | -3.00 | -3.00 | - | -5.36 Billion | -7.13 Billion | -1 Billion |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | -5.36 Billion | -7.13 Billion | -1 Billion |
Financing Cash Flow | -1.94 Billion | 183.68 Million | 930.19 Million | -5.25 Billion | -15.88 Billion | -7.04 Billion |
Debt repayment | -1.94 Billion | -183.68 Million | -930.19 Million | -5.25 Billion | -15.88 Billion | -8.96 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -1.26 Billion | -521.8 Million | 2.72 Billion | -968.21 Million | 1.92 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 5.98 Billion | 3.47 Billion | 3.4 Billion | 2.89 Billion | 6.15 Billion | 5.32 Billion |
Cash at end of period | 7.19 Billion | 5.98 Billion | 3.47 Billion | 3.4 Billion | 3.4 Billion | 2.89 Billion |
Capital Expenditure | -3.00 | -3.00 | - | -5.36 Billion | -7.13 Billion | -1 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 1.2 Billion | 2.5 Billion | 70.86 Million | 514.29 Million | -2.74 Billion | -2.43 Billion |
Free Cash Flow | 3.22 Billion | 2.24 Billion | -859.32 Million | 5.77 Billion | 13.13 Billion | 4.61 Billion |
CELL
4825
SCZC
LONTE
0JR1
AWAEF